Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/193423
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBonaventura, Jordi-
dc.contributor.authorNavarro Brugal, Gemma-
dc.contributor.authorCasadó Anguera, Verònica-
dc.contributor.authorAzdad, Karima-
dc.contributor.authorRea, William-
dc.contributor.authorMoreno Guillén, Estefanía-
dc.contributor.authorBrugarolas Campillos, Marc-
dc.contributor.authorMallol Montero, Josefa-
dc.contributor.authorCanela Campos, Enric I.-
dc.contributor.authorLluís i Biset, Carme-
dc.contributor.authorCortés Tejedor, Antonio-
dc.contributor.authorVolkow, Nora D.-
dc.contributor.authorSchiffmann, Serge N.-
dc.contributor.authorFerré, Sergi-
dc.contributor.authorCasadó, Vicent-
dc.date.accessioned2023-02-10T17:52:06Z-
dc.date.available2023-02-10T17:52:06Z-
dc.date.issued2015-07-07-
dc.identifier.issn0027-8424-
dc.identifier.urihttp://hdl.handle.net/2445/193423-
dc.description.abstractAdenosine A2A receptor (A2AR)-dopamine D2 receptor (D2R) heteromers are key modulators of striatal neuronal function. It has been suggested that the psychostimulant effects of caffeine depend on its ability to block an allosteric modulation within the A2AR-D2R heteromer, by which adenosine decreases the affinity and intrinsic efficacy of dopamine at the D2R. We describe novel unsuspected allosteric mechanisms within the heteromer by which not only A2AR agonists, but also A2AR antagonists, decrease the affinity and intrinsic efficacy of D2R agonists and the affinity of D2R antagonists. Strikingly, these allosteric modulations disappear on agonist and antagonist coadministration. This can be explained by a model that considers A2AR-D2R heteromers as heterotetramers, constituted by A2AR and D2R homodimers, as demonstrated by experiments with bioluminescence resonance energy transfer and bimolecular fluorescence and bioluminescence complementation. As predicted by the model, high concentrations of A2AR antagonists behaved as A2AR agonists and decreased D2R function in the brain.-
dc.format.extent10 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherNational Academy of Sciences-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1073/pnas.1507704112-
dc.relation.ispartofProceedings of the National Academy of Sciences of the United States of America - PNAS, 2015, vol. 112, num. 27, p. E3609-E3618-
dc.relation.urihttps://doi.org/10.1073/pnas.1507704112-
dc.rights(c) Bonaventura, Jordi et al., 2015-
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)-
dc.subject.classificationAdenosina-
dc.subject.classificationDopamina-
dc.subject.classificationCafeïna-
dc.subject.otherAdenosine-
dc.subject.otherDopamine-
dc.subject.otherCaffeine-
dc.titleAllosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec652885-
dc.date.updated2023-02-10T17:52:06Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid26100888-
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)

Files in This Item:
File Description SizeFormat 
652885.pdf1.89 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.